STAR Financial Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,646
Closed -$243K 113
2026
Q1
$243K Buy
+8,646
New +$230K 0.11% 91
2025
Q4
Sell
-9,714
Closed -$248K 118
2025
Q3
$248K Sell
9,714
-60
-0.6% -$1.48K 0.15% 104
2025
Q2
$237K Sell
9,774
-1,644
-14% -$38.3K 0.15% 101
2025
Q1
$289K Sell
11,418
-1,032
-8% -$27K 0.21% 81
2024
Q4
$330K Buy
12,450
+403
+3% +$10.9K 0.24% 76
2024
Q3
$349K Sell
12,047
-1,275
-10% -$37.2K 0.23% 85
2024
Q2
$373K Buy
13,322
+2,175
+20% +$59.9K 0.29% 83
2024
Q1
$309K Buy
11,147
+50
+0.5% +$1.39K 0.26% 79
2023
Q4
$319K Sell
11,097
-6,652
-37% -$201K 0.29% 78
2023
Q3
$589K Sell
17,749
-1,592
-8% -$56.3K 0.6% 41
2023
Q2
$709K Sell
19,341
-128
-0.7% -$4.98K 0.66% 38
2023
Q1
$794K Sell
19,469
-258
-1% -$11.1K 0.77% 34
2022
Q4
$1.01M Buy
+19,727
New +$946K 1% 29

Other funds holding PFE

STAR Financial Bank's PFE Position: Q2 2026 in Review

STAR Financial Bank sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,646 shares — an estimated $243K sold.

STAR Financial Bank first reported a position in PFE in Q4 2022 and held it in 13 quarters. The position peaked at $1.01M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • STAR Financial Bank reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • STAR Financial Bank sold 8,646 Pfizer shares in Q2 2026, an estimated $243K.
  • STAR Financial Bank first reported a position in Pfizer in Q4 2022 and held it in 13 quarters.
  • STAR Financial Bank's Pfizer position peaked at $1.01M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on STAR Financial Bank's 13F filing for Q2 2026, filed 7 Aug 2026.